NK
Najat Khan
DELAYED 1 MONTH
Director, CEO and President
RECURSION PHARMACEUTICALS, INC.
Filings
3
Companies
1
Latest
Jun 5, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
65
RXRXCLUSTER 4
RECURSION PHARMACEUTICALS, INC.
Najat Khan
Director, CEO and President
Sale
$84.5K
23,588 sh
Jun 5 9:02 PM
Jun 5, 2026
59
RXRXCLUSTER 2
RECURSION PHARMACEUTICALS, INC.
Najat Khan
Director, CEO and President
Sale
$94.7K
28,298 sh
Mar 11 9:41 PM
Mar 9, 2026